Search results for: Events
Filter search results
Medicines, Health and the Poor World
1 April 1982
…attracted some criticism (Raghavan 1981, Loraine 1981, Lancet 1981). And it may be thought not to have influenced the immediate course of world events to any great extent. Yet once…
Insights From 2022 and Emerging Issues in 2023
7 December 2022, 12:00am
Join our industry-leading experts as they present: 60 years of OHE: Reflecting on our 60th anniversary year and sharing key insights from our global projects and events. The ‘silent pandemic’:…
Julia Toth
19 September 2023
Julia Toth joined OHE in August 2023 and leads digital marketing across social media, email campaigns, paid advertising, and events. She promotes OHE’s research, reports, and webinars to health economists,…
Privacy Policy
…about activities that may be of interest to you. This might be about our work, government or industry initiatives, events, membership or other matters. We will only send these to…
Contact & engagement
Contact & feedback For inquiries, please contact us at info@ohe.org Newsletter subscription Sign up to our newsletter service Upcoming events Upcoming Events Carer quality of life in HTA: from measurement…
OHE’s submission to a parliamentary inquiry on UK drug shortages
6 October 2025
…rise in adverse events from taking a substitute drug or prescribing errors, and worse outcomes associated with the prescribed treatment alternatives (or lack thereof). Our research demonstrates that the costs…
OHE Lunchtime Seminars: Steven Pearson and Janel Hanmer
4 October 2018
…you would like to attend one (or both) of the seminars mentioned above, please send an email to ohegeneral@ohe.org. Please visit the events page of our website for more details….
Rare Disease Day 2022
28 February 2022
…will soon be available on-demand via the OHE website, where you can download the presentations from OHE experts and other industry thought-leaders on the topic. Email events@ohe.org for further information….
Biosimilars: Modelling the Evolution of the Market
16 June 2010
…can both minimise adverse events by better defining any safety risks and help demonstrate the value for money offered by biosimilars. Prof Towse is Director of the OHE and Dr Mestre-Ferrandiz is…